Tissue average binding and equilibrium distribution: An example with heparin in arterial tissues

Biophysical Journal

Volumn 70, Issue 3, 1996, Pages 1553-1559

  Lovich, Mark A ^a   Edelman, Elazer R ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PENICILLIN G; STREPTOMYCIN;

ADVENTITIA; ANIMAL TISSUE; ARTERY; ARTICLE; BINDING AFFINITY; BINDING SITE; DISSOCIATION CONSTANT; DRUG DISTRIBUTION; ENDOTHELIUM; NONHUMAN; SWINE; TISSUE;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 0030048879     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(96)79719-9     Document Type: Article

References (25)

1. Barzu, T., P Molho, G. Tobelem, M. Petitou, and J. Caen. 1985. Binding and endocytosis of heparin by endothelial cells in culture. Biochim. Biophys. Acta. 845:196-203.
2. Barzu, T., J. L. M. L. V. Rijn, M. Petitou, P. Molho, and O. Tobelem. 1986. Endothelial binding sites for heparin: specificity and role in heparin neutralization. Biochem. J. 238:847-854.
3. Castellot, J. J. J , M. L. Addonizio, R. D Rosenberg, and M. J. Karnovsky. 1981. Cultured endothelial cells produce a heparin-like inhibition of smooth muscle growth. J. Cell. Biol. 90:372-379.
4. Castellot, J. J. J., D. L. Cochran, and M J Karnovsky. 1985a. Effect of heparin on vascular smooth muscle cells. I. Cell metabolism. J. Cell Physiol. 124:21-28.
5. Castellot, J J. J., K. Wong, B. Herman, R. L. Hoover, D. F. Albertini, T. C. Wright, B. L. Caleb, and M J. Karnovsky. 1985b. Binding and internalization of heparin by vascular smooth muscle cells. J. Cell. Physiol. 124:13-20.
6. Castellot, J. J J., T. C. Wright, and M. J. Karnovsky. 1987. Regulation of vascular smooth muscle cell growth by heparin and heparan sulphate Semin. Thromb. Hemost. 13:489-503.
7. Clowes, A W., M. A. Reidy, and M. M. Clowes. 1983. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle cell proliferation following endothelial injury. Lab. Invest. 49:327-333.
8. Edelman, E. R., D. A. Adams, and M. J. Karnovsky. 1990. Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc. Natl. Acad. Sci. USA. 87: 3773-3777.
9. Edelman, E. R , and J M. Karnovsky. 1994. Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis. Circulation. 89:770-776.
10. Edelman, E., M. Nugent, and M. Karnovsky. 1993. Perivascular and intravenous bFGF administration: vascular and solid organ deposition. Proc. Natl. Acad. Sci. USA. 30.1513-1517.
11. Ellis, S. G., G. S. Roubin, S. B. King, J. S Douglas. W. S. Weintraub, R. G. Thomas, and W. R. Cox. 1988. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation. 77:372-379.
12. Ellis, S. G., G. S. Roubin, J Wilentz, J Douglas, and S. King. 1989 Effect of 18 to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am. Heart J. 117:777-782
13. Glimelius, B , C Busch, and M. Hook. 1978. Binding of heparin on the surface of cultured human endothelial cells. Thromb. Res. 12:773-782.
14. Haas, K., S. Phillips, A. Comerota, and J. White, 1991. The architecture of adventitial elastin in the canine infrarenal aorta. Anat. Rec. 230:86-96
15. Hiebert, L. M., and N. M McDuffie 1989. The intracellular uptake and protracted release of exogenous heparins by cultured endothelial cells. Artery. 16.208-222.
16. Ip, J. H., V. Fuster, L. Badimon, J. Badimon, M. B. Taubman, and J. H. Chesebro. 1990. Syndromes of accelerated atherosclerosis role of vascular injury and smooth muscle proliferation. J. Am. Coll. Cardiol. 15:1667-1687.
17. Lehmann, K. G., R. J. Doria, J. M. Feuer, P. X. Hall, and D. T. Hoang. 1991. Paradoxical increase in restenosis rate with chronic heparin use: final results of a randomized trial. J. Am. Coll. Cardiol. 17:181A. (Abstr )
18. Lovich, M., and E. Edelman. 1995. Mechanisms of transmural heparin transport in the rat abdominal aorta after local vascular delivery. Circ. Res. 77:1143-1150.
19. Murata, K., T. Motayama, and C. Kotake. 1986. Collagen types in various layers of the human aorta and their changes with the atherosclerotic process. Atherosclerosis. 60:251-262.
20. Nugent, M. A., and E. R. Edelman. 1992. Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperativity. Biochemistry. 31:8876-8883.
21. Press, W., B. Flannery, S Teukolsky, and W. Vetterling. 1986. Modeling of data: nonlinear models. In Numerical Recipes. Cambridge University Press, Cambridge. 521-528.
22. 125I) heparin and low molecular weight heparin fraction CY 222 to endothelium in culture. Folia Haematol. 114:429-436.
23. Rogers, C., M. J. Karnovsky, and E. R. Edelman. 1993. Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration. Circulation. 88:1215-1221.
24. San Antonio, J. D., J. Slover, J. Lawler, M. J. Karnovsky, and A. D. Lander. 1993. Specificity in the interactions of extracellular matrix proteins with subpopulations of the glycosaminoglycan heparin. Biochemistry. 32:4746-4755.
25. Vannucchi, S., F. Pasquali, V. Chiarugi, and M. Ruggiero. 1986. Internalization and metabolism of endogenous heparin by cultured endothelial cells. Biochem. Biophys. Res. Commun. 1140:294-301.